Elite Pharmaceuticals, Inc. (ELTP) Free cash flow 2017–2026
Elite Pharmaceuticals, Inc. (ELTP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$22.8MFY2026 · since FY2017: -$9.0M → $22.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $22.8M | +291.4% |
| FY2025 | $5.8M | +244.2% |
| FY2024 | -$4.0M | -68.7% |
| FY2023 | -$2.4M | -139.9% |
| FY2022 | $6.0M | +109.8% |
| FY2021 | $2.9M | +256.6% |
| FY2020 | -$1.8M | +73.2% |
| FY2019 | -$6.8M | -36.5% |
| FY2018 | -$5.0M | +44.4% |
| FY2017 | -$9.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice